BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16210333)

  • 21. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies.
    Bataille R; Chappard D; Basle MF
    Blood; 1996 Jun; 87(11):4762-9. PubMed ID: 8639847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.
    Landgren O; Graubard BI; Kumar S; Kyle RA; Katzmann JA; Murata K; Costello R; Dispenzieri A; Caporaso N; Mailankody S; Korde N; Hultcrantz M; Therneau TM; Larson DR; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2017 Oct; 7(10):e618. PubMed ID: 29053158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture risk in monoclonal gammopathy of undetermined significance.
    Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
    J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.
    Landgren O; Graubard BI; Katzmann JA; Kyle RA; Ahmadizadeh I; Clark R; Kumar SK; Dispenzieri A; Greenberg AJ; Therneau TM; Melton LJ; Caporaso N; Korde N; Roschewski M; Costello R; McQuillan GM; Rajkumar SV
    Leukemia; 2014 Jul; 28(7):1537-42. PubMed ID: 24441287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting.
    Singh J; Dudley AW; Kulig KA
    J Lab Clin Med; 1990 Dec; 116(6):785-9. PubMed ID: 2246554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
    Landgren O; Zeig-Owens R; Giricz O; Goldfarb D; Murata K; Thoren K; Ramanathan L; Hultcrantz M; Dogan A; Nwankwo G; Steidl U; Pradhan K; Hall CB; Cohen HW; Jaber N; Schwartz T; Crowley L; Crane M; Irby S; Webber MP; Verma A; Prezant DJ
    JAMA Oncol; 2018 Jun; 4(6):821-827. PubMed ID: 29710195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
    Lolin YI; Chow J; Wickham NW
    Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
    Fujimura K; Sugiyama A; Akita T; Ohisa M; Nagashima S; Katayama K; Maeda R; Tanaka J
    Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.
    Wadhera RK; Rajkumar SV
    Mayo Clin Proc; 2010 Oct; 85(10):933-42. PubMed ID: 20713974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans.
    Liu LW; Wang M; Grandhi N; Schroeder MA; Thomas T; Vargo K; Gao F; Sanfilippo KM; Chang SH
    J Hematol Oncol; 2024 Jan; 17(1):3. PubMed ID: 38191467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis.
    Bouvard B; Royer M; Chappard D; Audran M; Hoppé E; Legrand E
    Joint Bone Spine; 2010 Mar; 77(2):120-4. PubMed ID: 20097594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.
    Yoshida Y; Oguma S; Ohno H; Nakabo Y; Katsurada T; Kawahara M; Kawabata H
    Int J Hematol; 2014 Jun; 99(6):721-5. PubMed ID: 24687918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL; Sarid R
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fracture risk in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M
    Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
    Landgren O; Kyle RA; Hoppin JA; Beane Freeman LE; Cerhan JR; Katzmann JA; Rajkumar SV; Alavanja MC
    Blood; 2009 Jun; 113(25):6386-91. PubMed ID: 19387005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method.
    Vachon CM; Murray J; Allmer C; Larson D; Norman AD; Sinnwell JP; Dispenzieri A; Kleinstern G; Visram A; Kyle RA; Rajkumar SV; Slager SL; Kumar SK; Murray DL
    Blood Adv; 2022 Jun; 6(12):3746-3750. PubMed ID: 35316833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Madsen KM; Sørensen HT; Schønheyder HC; Ibsen JS; Dahlerup JF
    Eur J Haematol; 1998 Aug; 61(2):140-4. PubMed ID: 9714528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoclonal gammopathy of uncertain significance (MGUS) and ionizing radiation].
    Taino G; Buonocore C; Stanga A; Imbriani M
    G Ital Med Lav Ergon; 2020 Dec; 42(4):292-297. PubMed ID: 33600657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.